Stay updated on FB825 Safety & Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the FB825 Safety & Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the FB825 Safety & Efficacy in Atopic Dermatitis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1; no visible changes to study content or functionality are indicated.SummaryDifference0.1%

- Check20 days agoChange DetectedA minor site-version update was applied (Revision: v3.4.1) replacing the previous v3.4.0. This change does not affect study details or user actions, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedShow glossary was added to the page, and several metadata items were updated: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. The previous labels and data—Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4—were removed or replaced.SummaryDifference0.2%

- Check42 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter updates show Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure link. This is a minor site maintenance update that does not affect study content or user actions.SummaryDifference0.1%

- Check91 days agoChange Detected- Revision: v3.3.2 replaces Revision: v3.2.0 on the page.SummaryDifference0.1%

Stay in the know with updates to FB825 Safety & Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FB825 Safety & Efficacy in Atopic Dermatitis Clinical Trial page.